Institutional Ownership
Entera Bio Ltd
CUSIP M40527109SHSENTXQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
18.2%
Max % of class reported
Institutional Holders
26
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.6% | 1.18M | SEC |
| 2 | Apr 2, 2025 | Opko Health, Inc. | 13G | 8.1% | 3.69M | SEC |
| 3 | Jan 6, 2025 | Point72 Asset Management, L.P. | 13G | 6.8% | 2.70M | SEC |
| 4 | Nov 20, 2024 | Knoll Capital Management, LLC | 13G/A | 15.0% | 5.88M | SEC |
| 5 | Aug 20, 2024 | Centillion Fund Inc. | 13G/A | 6.7% | 2.40M | SEC |
| 6 | Jan 16, 2024 | Knoll Capital Management, LLC | 13G/A | 10.0% | 3.88M | SEC |
| 7 | Feb 14, 2023 | Ra Capital Management, L.P. | 13G/A | 1.0% | 296.0K | SEC |
| 8 | Nov 18, 2022 | Centillion Fund Inc. | 13G/A | 8.3% | 2.40M | SEC |
| 9 | Nov 18, 2022 | Centillion Fund Inc. | 13G/A | 4.4% | 1.27M | SEC |
| 10 | Nov 18, 2022 | Centillion Fund Inc. | 13G/A | 4.4% | 1.27M | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Entera Bio Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 5.88M | $6.47M |
| 2 | Renaissance Technologies LLC | 473.4K | $525.5K |
| 3 | Parkman Healthcare Partners LLC | 288.7K | $320.4K |
| 4 | Citadel Advisors LLC | 245.6K | $272.6K |
| 5 | Seven Fleet Capital Management LP | 205.5K | $228.2K |
| 6 | Marshall Wace, LLP | 195.8K | $217.3K |
| 7 | Northern Trust Corp | 146.9K | $163.0K |
| 8 | Xtx Topco Ltd | 131.6K | $146.1K |
| 9 | Schonfeld Strategic Advisors LLC | 55.2K | $61.3K |
| 10 | Signature Estate & Investment Advisors LLC | 47.3K | $52.5K |